Regeneron Pharmaceuticals, Inc. (REGN) reported second-quarter 2025 adjusted earnings per share (EPS) of $12.89, which ...

Eli Lilly › Great businesses have a habit of remaining so even when market volatility arises. The stock market is cyclical, ...

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...

France's CAC 40 fell 1.8%, and Germany's DAX dropped 1.7%, underlining the significant impact the new measures are having across Europe's largest economies.

Novo Nordisk is a healthcare stock that is down 50% in 2025. Is NVO stock undervalued at current levels or can it move lower over the next 12 months?

The FDA had set an Aug. 19 target action date for the company's application, which was seeking a green light for Eylea HD for the treatment of macular edema following retinal vein occlusion and for ...

Eli Lilly is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Learn more on LLY stock here.

Novo Nordisk on Tuesday slashed its forecast for 2025 sales growth due to competition from compounded, or copycat, versions ...

Indian benchmark indices Sensex and Nifty50 traded in the red on Friday after the U.S. imposed steep tariffs on multiple trade partners and reaffirmed a 25% import duty on Indian goods.

Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen pharmaceutical groups arguing for them to lower U.S. prescription drug ...

The e-commerce behemoth reported sharp increases in sales and profit, partly fueled by the growth of its cloud-computing business. Still, shares fell 8% premar ...

The pan-European STOXX 600 index fell 1.3% by 0915 GMT, down for the third straight session and on track to end the week in the red ...